跳转至内容
Merck

G7163

Sigma-Aldrich

α-半乳糖苷酶,位置特异性 来源于大肠杆菌

recombinant, expressed in E. coli, buffered aqueous solution

别名:

1,6-alpha-D-galactoside galactohydrolase, alpha-Galactosidase, melibiase

登录查看公司和协议定价


About This Item

CAS号:
MDL號碼:
分類程式碼代碼:
12352204
NACRES:
NA.32

重組細胞

expressed in E. coli

品質等級

形狀

buffered aqueous solution

比活性

≥20 units/mg protein

分子量

80 kDa

運輸包裝

wet ice

儲存溫度

2-8°C

基因資訊

Escherichia coli CFT073 ... melA(1037886)

生化/生理作用

从复杂的碳水化合物和糖蛋白中裂解 α(1→3)-和 α(1→6)-连接的非还原性末端半乳糖。在 pH 必须为中性或更高的条件下(例如,活细胞),这种方法对于去除 α-连接的半乳糖特别有效。

單位定義

在 pH 6.5,25°C 下,一个单位每分钟将水解 1 μ 摩尔对硝基苯基 α-D-吡喃半乳糖苷。

外觀

该产品是无菌过滤的水性缓冲溶液。

抑制劑

产品编号
说明
价格

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

K Schmid et al.
European journal of biochemistry, 67(1), 95-104 (1976-08-01)
The utilization by Escherichia coli K12 of raffinose as sole carbon source depends on a new raffinose transport system, an invertase and an alpha-galactosidase specified by the Raf-plasmid D1021. The alpha-galactosidase was purified to homogeneity from a mutant strain with
Romain Merceron et al.
The Journal of biological chemistry, 287(47), 39642-39652 (2012-09-27)
The α-galactosidase AgaA from the thermophilic microorganism Geobacillus stearothermophilus has great industrial potential because it is fully active at 338 K against raffinose and can increase the yield of manufactured sucrose. AgaB has lower affinity for its natural substrates but
Hongwei Gao et al.
Artificial cells, nanomedicine, and biotechnology, 41(1), 32-36 (2012-10-04)
Enzymatical conversion of A or B RBCs into group O RBCs (ECORBCs) was achieved by using α-N-acetylgalactosaminidase and α-galactosidase, respectively. Now, we initiated AB to O-RBC conversion by using these two enzymes together. But α-N-acetylgalactosaminidase and α-galactosidase's preserving and their
Dominique P Germain et al.
Orphanet journal of rare diseases, 7, 91-91 (2012-11-28)
Fabry disease (FD) is a genetic disorder resulting from deficiency of the lysosomal enzyme α-galactosidase A (α-Gal A), which leads to globotriaosylceramide (GL-3) accumulation in multiple tissues. We report on the safety and pharmacodynamics of migalastat hydrochloride, an investigational pharmacological
Costanza Simoncini et al.
The neurologist, 18(6), 413-414 (2012-11-02)
Fabry disease (FD) is a rare, X-linked lysosomal storage disorder with multiorgan involvement. FD is caused by a partial or total deficit of α-galactosidase A enzyme, which is responsible for the accumulation of glycosphingolipids in a variety of cell types.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门